1.Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects.
Yan CHEN ; Chen CHEN ; Xiaojuan ZHANG ; Chuanchuan HE ; Pengxuan ZHAO ; Minsi LI ; Ting FAN ; Ruicong YAN ; Yao LU ; Robert J LEE ; Muhammad Waseem KHAN ; Muhammad SARFRAZ ; Xiang MA ; Tan YANG ; Guangya XIANG
Acta Pharmaceutica Sinica B 2020;10(6):1106-1121
Platinum-based chemotherapy is used for non-small cell lung cancer (NSCLC). However, it has side effects and minimum efficacy against lung cancer metastasis. In this study, platinum-curcumin complexes were loaded into pH and redox dual-responsive nanoparticles (denoted as Pt-CUR@PSPPN) to facilitate intracellular release and synergistic anti-cancer effects. Pt-CUR@PSPPN was prepared by a nano-precipitation method and had a diameter of ∼100 nm. The nanoparticles showed increased anti-cancer effects both and . In addition, Pt-CUR@PSPPN blocked PI3K/AKT signal transduction pathway and inhibited MMP2 and VEGFR2, resulting in enhanced anti-metastatic activity. Furthermore, reduced side effects were also observed. In conclusion, Pt-CUR@PSPPN provided a novel and attractive therapeutic strategy for NSCLC.
2.A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving
Xiaojuan ZHANG ; Chuanchuan HE ; Yun SUN ; Xiaoguang LIU ; Yan CHEN ; Chen CHEN ; Ruicong YAN ; Ting FAN ; Tan YANG ; Yao LU ; Jun LUO ; Xiang MA ; Guangya XIANG
Acta Pharmaceutica Sinica B 2021;11(11):3608-3621
Drug transportation is impeded by various barriers in the hypoxic solid tumor, resulting in compromised anticancer efficacy. Herein, a solid lipid monostearin (MS)-coated CaO2/MnO2 nanocarrier was designed to optimize doxorubicin (DOX) transportation comprehensively for chemotherapy enhancement. The MS shell of nanoparticles could be destroyed selectively by highly-expressed lipase within cancer cells, exposing water-sensitive cores to release DOX and produce O2. After the cancer cell death, the core-exposed nanoparticles could be further liberated and continue to react with water in the tumor extracellular matrix (ECM) and thoroughly release O2 and DOX, which exhibited cytotoxicity to neighboring cells. Small DOX molecules could readily diffuse through ECM, in which the collagen deposition was decreased by O2-mediated hypoxia-inducible factor-1 inhibition, leading to synergistically improved drug penetration. Concurrently, DOX-efflux-associated P-glycoprotein was also inhibited by O2, prolonging drug retention in cancer cells. Overall, the DOX transporting processes from nanoparticles to deep tumor cells including drug release, penetration, and retention were optimized comprehensively, which significantly boosted antitumor benefits.